Historical perspective of peptidomics

EuPA Open Proteomics

Volumn 3, Issue , 2014, Pages 171-182

  Schrader, Michael ^a   Schulz Knappe, Peter ^b   Fricker, Lloyd D ^c  

^a UNIVERSITY OF APPLIED SCIENCES WEIHENSTEPHAN TRIESDORF   (Germany)

^b PROTAGEN AG   (Germany)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarker discovery; Neuropeptides; Peptide hormones; Peptide research; Peptidome; Peptidomic

Indexed keywords

BIOLOGICAL MARKER; NEUROPEPTIDE; PEPTIDE HORMONE;

ANALYTIC METHOD; ARTICLE; CLINICAL RESEARCH; GENOME ANALYSIS; HISTORY OF MEDICINE; HUMAN; HUMAN GENOME; INTERMETHOD COMPARISON; MOLECULAR DYNAMICS; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDOMICS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84902506505     PISSN: None     EISSN: 22129685     Source Type: Journal    
DOI: 10.1016/j.euprot.2014.02.014     Document Type: Article

References (141)

1. Bayliss W.M., Starling E.H. The mechanism of pancreatic secretion. J Physiol 1902, 28:325-353.
2. Tatemoto K., Rokaeus A., Jornvall H., McDonald T.J., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983, 164:124-128.
3. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982, 296:659-660.
4. Tatemoto K., Mutt V. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 1980, 285:417-418.
5. Sigafoos J., Chestnut W.G., Merrill B.M., Taylor L.C., Diliberto E.J., Viveros O.H. Novel peptides from adrenomedullary chromaffin vesicles. J Anat 1993, 183(Pt 2):253-264.
6. Forssmann W.G., Birr C., Carlquist M., Christmann M., Finke R., Henschen A., et al. The auricular myocardiocytes of the heart constitute an endocrine organ. Characterization of a porcine cardiac peptide hormone, cardiodilatin-126. Cell Tissue Res 1984, 238:425-430.
7. Schulz-Knappe P., Schrader M., Standker L., Richter R., Hess R., Jurgens M., et al. Peptide bank generated by large-scale preparation of circulating human peptides. J Chromatogr A 1997, 776:125-132.
8. Bensch K.W., Raida M., Magert H.J., Schulz-Knappe P., Forssmann W.G. hBD-1: a novel beta-defensin from human plasma. FEBS Lett 1995, 368:331-335.
9. Schulz-Knappe P., Magert H.J., Dewald B., Meyer M., Cetin Y., Kubbies M., et al. HCC-1, a novel chemokine from human plasma. J Exp Med 1996, 183:295-299.
10. Desiderio D.M. Mass spectrometry, high performance liquid chromatography, and brain peptides. Biopolymers 1996, 40:257-264.
11. Desiderio D.M. Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid. J Chromatogr B: Biomed Sci Appl 1999, 731:3-22.
12. Yan L., Tseng J.L., Desiderio D.M. Mass spectrometric detection of preproenkephalin A-derived peptides in bovine pituitary. Life Sci 1994, 55:1937-1944.
13. Richter R., Schulz-Knappe P., Schrader M., Standker L., Jurgens M., Tammen H., et al. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr B: Biomed Sci Appl 1999, 726:25-35.
14. Skold K., Svensson M., Kaplan A., Bjorkesten L., Astrom J., Andren P.E. A neuroproteomic approach to targeting neuropeptides in the brain. Proteomics 2002, 2:447-454.
15. Tammen H., Schulte I., Hess R., Menzel C., Kellmann M., Mohring T., et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5:3414-3422.
16. Fricker L.D., Snyder S.H. Enkephalin convertase: purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. Proc Natl Acad Sci USA 1982, 79:3886-3890.
17. Fricker L.D., Supattapone S., Snyder S.H. Enkephalin convertase: a specific enkephalin synthesizing carboxypeptidase in adrenal chromaffin granules, brain, and pituitary gland. Life Sci 1982, 31:1841-1844.
18. Naggert J.K., Fricker L.D., Varlamov O., Nishina P.M., Rouille Y., Steiner D.F., et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995, 10:135-142.
19. Fricker L.D., Berman Y.L., Leiter E.H., Devi L.A. Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing. J Biol Chem 1996, 271:30619-30624.
20. Che F.Y., Yan L., Li H., Mzhavia N., Devi L.A., Fricker L.D. Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) mice. Proc Natl Acad Sci USA 2001, 98:9971-9976.
21. Fricker L.D., McKinzie A.A., Sun J., Curran E., Qian Y., Yan L., et al. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 2000, 20:639-648.
22. Gomes I., Aryal D.K., Wardman J.H., Gupta A., Gagnidze K., Rodriguiz R.M., et al. GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proc Natl Acad Sci USA 2013, 110:16211-16216.
23. Wardman J.H., Berezniuk I., Di S., Tasker J.G., Fricker L.D. ProSAAS-derived peptides are colocalized with neuropeptide Y and function as neuropeptides in the regulation of food intake. PLoS ONE 2011, 6:e28152.
24. Morgan D.J., Wei S., Gomes I., Czyzyk T., Mzhavia N., Pan H., et al. The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation. J Neurochem 2010, 113:1275-1284.
25. Wei S., Feng Y., Che F., Pan H., Mzhavia N., Devi L.A., et al. Obesity and diabetes in transgenic mice expressing proSAAS. J Endocrinol 2004, 180:357-368.
26. Verhaert P.D.E.M., Pinkse M.W.H., Prieto-Conaway M.C., Kellmann M. A short history of insect (neuro) peptidomics-a personal story of the birth and youth of an excellent model for studying peptidome biology. Peptidomics: methods and applications 2008, 25-54. John Wiley & Sons, Hoboken. M. Soloviev, C. Shaw, P. Andren (Eds.).
27. Schrader M., Schulz-Knappe P. Peptidomics for human body fluids by combination of chromatography and mass spectrometry. J Biomol Tech 2000, 11:28.
28. Verhaert P., Uttenweiler-Joseph S., Vries M., de Loboda A., Ens W., Standing K.G. Matrix-assisted laser desorption/ionization quadrupole time-of-flight mass spectrometry: an elegant tool for peptidomics. Proteomics 2001, 1:118-131.
29. Clynen E., Baggerman G., Veelaert D., Cerstiaens A., van der Horst D., Harthoorn L., et al. Peptidomics of the pars intercerebralis-corpus cardiacum complex of the migratory locust, Locusta migratoria. Eur J Biochem 2001, 268:1929-1939.
30. Schrader M., Schulz-Knappe P. Peptidomics technologies for human body fluids. Trends Biotechnol 2001, 19:S55-S60.
31. Schulz-Knappe P., Zucht H.D., Heine G., Jurgens M., Hess R., Schrader M. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb Chem High Throughput Screen 2001, 4:207-217.
32. Bergquist J., Ekman R. Future aspects of psychoneuroimmunology - lymphocyte peptides reflecting psychiatric disorders studied by mass spectrometry. Arch Physiol Biochem 2001, 109:369-371.
33. Minamino N. Peptidome: the fact-database for endogenous peptides. Tanpakushitsu Kakusan Koso 2001, 46:1510-1517.
34. Peptide separation and analysis. J Chromatogr B: Biomed Sci Appl 2004, 803:1-172.
35. Analysis of peptides. J Sep Sci 2008, 31:425-598.
36. Peptidomics in drug development 2005, Editio Cantor, Aulendorf. D. Gaenshirt, F. Harms, S. Rohmann (Eds.).
37. Peptidomics: methods and applications 2008, John Wiley & Sons, Hoboken. M. Soloviev, P. Andrén, C. Shaw (Eds.).
38. Dunn M.J. Two-dimensional gel electrophoresis of proteins. J Chromatogr 1987, 418:145-185.
39. Mohring T., Kellmann M., Jurgens M., Schrader M. Top-down identification of endogenous peptides up to 9kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time-of-flight tandem mass spectrometry. J Mass Spectrom 2005, 40:214-226.
40. Wilkins M.R., Appel R.D., van Eyk J.E., Chung M.C.M., Gorg A., Hecker M., et al. Guidelines for the next 10 years of proteomics. Proteomics 2006, 6:4-8.
41. Falth M., Skold K., Svensson M., Nilsson A., Fenyo D., Andren P.E. Neuropeptidomics strategies for specific and sensitive identification of endogenous peptides. Mol Cell Proteomics 2007, 6:1188-1197.
42. Regnier F.E. High-performance liquid chromatography of biopolymers. Science 1983, 222:245-252.
43. Raida M., Schulz-Knappe P., Heine G., Forssmann W.G. Liquid chromatography and electrospray mass spectrometric mapping of peptides from human plasma filtrate. J Am Soc Mass Spectrom 1999, 10:45-54.
44. Finoulst I., Pinkse M., van Dongen W., Verhaert P. Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matrices. J Biomed Biotechnol 2011, 2011:245-291.
45. Fenn J.B., Mann M., Meng C.K., Wong S.F., Whitehouse C.M. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246:64-71.
46. Karas M., Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000daltons. Anal Chem 1988, 60:2299-2301.
47. Papayannopoulos I.A. The interpretation of collision-induced dissociation tandem mass spectra of peptides. Mass Spectrom Rev 1995, 14:49-73.
48. Wilm M., Shevchenko A., Houthaeve T., Breit S., Schweigerer L., Fotsis T., et al. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 1996, 379:466-469.
49. Hernandez P., Muller M., Appel R.D. Automated protein identification by tandem mass spectrometry: issues and strategies. Mass Spectrom Rev 2006, 25:235-254.
50. Pandey A., Mann M. Proteomics to study genes and genomes. Nature 2000, 405:837-846.
51. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
52. Schrader M., Jurgens M., Hess R., Schulz-Knappe P., Raida M., Forssmann W.G. Matrix-assisted laser desorption/ionisation mass spectrometry guided purification of human guanylin from blood ultrafiltrate. J Chromatogr A 1997, 776:139-145.
53. Ramstrom M., Bergquist J. Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry. FEBS Lett 2004, 567:92-95.
54. Baggerman G., Boonen K., Verleyen P., Loof A., de Schoofs L. Peptidomic analysis of the larval Drosophila melanogaster central nervous system by two-dimensional capillary liquid chromatography quadrupole time-of-flight mass spectrometry. J Mass Spectrom 2005, 40:250-260.
55. Sasaki K., Sato K., Akiyama Y., Yanagihara K., Oka M., Yamaguchi K. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res 2002, 62:4894-4898.
56. Conlon J.M., Kim J.B., Johansson A., Kikuyama S. Comparative peptidomics of the endocrine pancreas: islet hormones from the clawed frog Xenopus laevis and the red-bellied newt Cynops pyrrhogaster. J Endocrinol 2002, 175:769-777.
57. Minamino N., Tanaka J., Kuwahara H., Kihara T., Satomi Y., Matsubae M., et al. Determination of endogenous peptides in the porcine brain: possible construction of peptidome, a fact database for endogenous peptides. J Chromatogr B: Analyt Technol Biomed Life Sci 2003, 792:33-48.
58. Li L., Garden R.W., Sweedler J.V. Single-cell MALDI: a new tool for direct peptide profiling. Trends Biotechnol 2000, 18:151-160.
59. Baggerman G., Cerstiaens A., Loof A., de Schoofs L. Peptidomics of the larval Drosophila melanogaster central nervous system. J Biol Chem 2002, 277:40368-40374.
60. Levy F., Rabel D., Charlet M., Bulet P., Hoffmann J.A., Ehret-Sabatier L. Peptidomic and proteomic analyses of the systemic immune response of Drosophila. Biochimie 2004, 86:607-616.
61. Hummon A.B., Amare A., Sweedler J.V. Discovering new invertebrate neuropeptides using mass spectrometry. Mass Spectrom Rev 2006, 25:77-98.
62. Zheng H., Ojha P.C., McClean S., Graham C., Black N.D., Hughes J.G., et al. A computational approach for peptidomic analysis in taxonomic study of amphibian species. IEEE Trans Nanobiosci 2005, 4:241-247.
63. Jimenez C.R., Li K.W., Dreisewerd K., Mansvelder H.D., Brussaard A.B., Reinhold B.B., et al. Pattern changes of pituitary peptides in rat after salt-loading as detected by means of direct, semiquantitative mass spectrometric profiling. Proc Natl Acad Sci USA 1997, 94:9481-9486.
64. Uttenweiler-Joseph S., Moniatte M., Lagueux M., van Dorsselaer A., Hoffmann J.A., Bulet P. Differential display of peptides induced during the immune response of Drosophila: a matrix-assisted laser desorption ionization time-of-flight mass spectrometry study. Proc Natl Acad Sci USA 1998, 95:11342-11347.
65. Forssmann W.G., Schulz-Knappe P., Schrader M., Opitz H. Process for determining the status of an organism 1997, WO 98/07036.
66. Tammen H., Mohring T., Kellmann M., Pich A., Kreipe H.H., Hess R. Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display. Clin Chem 2004, 50:545-551.
67. Budde P., Schulte I., Appel A., Neitz S., Kellmann M., Tammen H., et al. Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes. Comb Chem High Throughput Screen 2005, 8:775-781.
68. Che F., Zhang X., Berezniuk I., Callaway M., Lim J., Fricker L.D. Optimization of neuropeptide extraction from the mouse hypothalamus. J Proteome Res 2007, 6:4667-4676.
69. Zhang X., Petruzziello F., Zani F., Fouillen L., Andren P.E., Solinas G., et al. High identification rates of endogenous neuropeptides from mouse brain. J Proteome Res 2012, 11:2819-2827.
70. Bucknall M., Fung K.Y.C., Duncan M.W. Practical quantitative biomedical applications of MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom 2002, 13:1015-1027.
71. Gygi S.P., Rist B., Griffin T.J., Eng J., Aebersold R. Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J Proteome Res 2002, 1:47-54.
72. Loo J.A., Edmonds C.G., Smith R.D. Primary sequence information from intact proteins by electrospray ionization tandem mass spectrometry. Science 1990, 248:201-204.
73. Reid G.E., McLuckey S.A. 'Top down' protein characterization via tandem mass spectrometry. J Mass Spectrom 2002, 37:663-675.
74. Cottrell J.S. Protein identification using MS/MS data. J Proteomics 2011, 74:1842-1851.
75. Menschaert G., Vandekerckhove T.T.M., Baggerman G., Schoofs L., Luyten W., van Criekinge W. Peptidomics coming of age: a review of contributions from a bioinformatics angle. J Proteome Res 2010, 9:2051-2061.
76. Clynen E., Baggerman G., Huybrechts J., Vanden Bosch L., Loof A., de Schoofs L. Peptidomics of the locust corpora allata: identification of novel pyrokinins (-FXPRLamides). Peptides 2003, 24:1493-1500.
77. Escoubas P., Quinton L., Nicholson G.M. Venomics: unravelling the complexity of animal venoms with mass spectrometry. J Mass Spectrom 2008, 43:279-295.
78. Petruzziello F., Fouillen L., Wadensten H., Kretz R., Andren P.E., Rainer G., et al. Extensive characterization of Tupaia belangeri neuropeptidome using an integrated mass spectrometric approach. J Proteome Res 2012, 11:886-896.
79. Maubert M., Quevrain E., Capton E., Grill J.P., Thomas G., Bachelet M., et al. High-resolution mass spectrometry and partial de novo sequencing constitute a useful approach for determining the profile of chemokine secretion following the stimulation of human intestinal epithelial cells. Rapid Commun Mass Spectrom 2013, 27:2179-2187.
80. Lamerz J., Selle H., Scapozza L., Crameri R., Schulz-Knappe P., Mohring T., et al. Correlation-associated peptide networks of human cerebrospinal fluid. Proteomics 2005, 5:2789-2798.
81. Svensson M., Skold K., Svenningsson P., Andren P.E. Peptidomics-based discovery of novel neuropeptides. J Proteome Res 2003, 2:213-219.
82. Che F., Lim J., Pan H., Biswas R., Fricker L.D. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol Cell Proteomics 2005, 4:1391-1405.
83. Nylander I., Stenfors C., Tan-No K., Mathe A.A., Terenius L. A comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides. Neuropeptides 1997, 31:357-365.
84. Mathe A.A., Stenfors C., Brodin E., Theodorsson E. Neuropeptides in brain: effects of microwave irradiation and decapitation. Life Sci 1990, 46:287-293.
85. Theodorsson E., Stenfors C., Mathe A.A. Microwave irradiation increases recovery of neuropeptides from brain tissues. Peptides 1990, 11:1191-1197.
86. Scholz B., Skold K., Kultima K., Fernandez C., Waldemarson S., Savitski M.M., et al. Impact of temperature dependent sampling procedures in proteomics and peptidomics-a characterization of the liver and pancreas post mortem degradome. Mol Cell Proteomics 2011, 10. M900229MCP200.
87. Che F., Fricker L.D. Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J Mass Spectrom 2005, 40:238-249.
88. Che F., Fricker L.D. Quantitation of neuropeptides in Cpe(fat)/Cpe(fat) mice using differential isotopic tags and mass spectrometry. Anal Chem 2002, 74:3190-3198.
89. Xiang F., Ye H., Chen R., Fu Q., Li L. N,N-dimethyl leucines as novel isobaric tandem mass tags for quantitative proteomics and peptidomics. Anal Chem 2010, 82:2817-2825.
90. Zhang R., Sioma C.S., Thompson R.A., Xiong L., Regnier F.E. Controlling deuterium isotope effects in comparative proteomics. Anal Chem 2002, 74:3662-3669.
91. Morano C., Zhang X., Fricker L.D. Multiple isotopic labels for quantitative mass spectrometry. Anal Chem 2008, 80:9298-9309.
92. Hummon A.B., Richmond T.A., Verleyen P., Baggerman G., Huybrechts J., Ewing M.A., et al. From the genome to the proteome: uncovering peptides in the Apis brain. Science 2006, 314:647-649.
93. Husson S.J., Clynen E., Baggerman G., Loof A., de Schoofs L. Discovering neuropeptides in Caenorhabditis elegans by two dimensional liquid chromatography and mass spectrometry. Biochem Biophys Res Commun 2005, 335:76-86.
94. Sweedler J.V., Li L., Rubakhin S.S., Alexeeva V., Dembrow N.C., Dowling O., et al. Identification and characterization of the feeding circuit-activating peptides, a novel neuropeptide family of aplysia. J Neurosci 2002, 22:7797-7808.
95. Fu Q., Goy M.F., Li L. Identification of neuropeptides from the decapod crustacean sinus glands using nanoscale liquid chromatography tandem mass spectrometry. Biochem Biophys Res Commun 2005, 337:765-778.
96. Li L., Kelley W.P., Billimoria C.P., Christie A.E., Pulver S.R., Sweedler J.V., et al. Mass spectrometric investigation of the neuropeptide complement and release in the pericardial organs of the crab, Cancer borealis. J Neurochem 2003, 87:642-656.
97. Ranc V., Petruzziello F., Kretz R., Argandona E.G., Zhang X., Rainer G. Broad characterization of endogenous peptides in the tree shrew visual system. J Proteomics 2012, 75:2526-2535.
98. Ferro E.S., Hyslop S., Camargo A.C.M. Intracellullar peptides as putative natural regulators of protein interactions. J Neurochem 2004, 91:769-777.
99. Fricker L.D. Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins. Mol Biosyst 2010, 6:1355-1365.
100. Zhang X., Pan H., Peng B., Steiner D.F., Pintar J.E., Fricker L.D. Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis. J Neurochem 2010, 112:1168-1179.
101. Zhang X., Che F., Berezniuk I., Sonmez K., Toll L., Fricker L.D. Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing. J Neurochem 2008, 107:1596-1613.
102. Lim J., Berezniuk I., Che F., Parikh R., Biswas R., Pan H., et al. Altered neuropeptide processing in prefrontal cortex of Cpe (fat/fat) mice: implications for neuropeptide discovery. J Neurochem 2006, 96:1169-1181.
103. Wardman J.H., Zhang X., Gagnon S., Castro L.M., Zhu X., Steiner D.F., et al. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. J Neurochem 2010, 114:215-225.
104. Pan H., Nanno D., Che F., Zhu X., Salton S.R., Steiner D.F., et al. Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry 2005, 44:4939-4948.
105. Che F., Vathy I., Fricker L.D. Quantitative peptidomics in mice: effect of cocaine treatment. J Mol Neurosci 2006, 28:265-275.
106. Decaillot F.M., Che F., Fricker L.D., Devi L.A. Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration. J Mol Neurosci 2006, 28:277-284.
107. Tammen H., Hess R., Rose H., Wienen W., Jost M. Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors-a proof of concept study. Peptides 2008, 29:2188-2195.
108. Jost M.M., Lamerz J., Tammen H., Menzel C., Meester I., de Lambeir A., et al. In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma. Biochem Pharmacol 2009, 77:228-237.
109. Tinoco A.D., Tagore D.M., Saghatelian A. Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform. J Am Chem Soc 2010, 132:3819-3830.
110. Foucher C., Schiffer E., Mischak H., Ansquer J., Wilbraham D. Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers. Proteomics Clin Appl 2011, 5:159-166.
111. Davidsson P., Brinkmalm A., Karlsson G., Persson R., Lindbjer M., Puchades M., et al. Clinical mass spectrometry in neuroscience. Proteomics and peptidomics. Cell Mol Biol (Noisy-le-grand) 2003, 49:681-688.
112. Selle H., Lamerz J., Buerger K., Dessauer A., Hager K., Hampel H., et al. Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. Comb Chem High Throughput Screen 2005, 8:801-806.
113. Sillard R., Jornvall H., Carlquist M., Mutt V. Chemical assay for cyst(e)ine-rich peptides detects a novel intestinal peptide ZF-1, homologous to a single zinc-finger motif. Eur J Biochem 1993, 211:377-380.
114. Neitz S., Jurgens M., Kellmann M., Schulz-Knappe P., Schrader M. Screening for disulfide-rich peptides in biological sources by carboxyamidomethylation in combination with differential matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2001, 15:1586-1592.
115. Zucht H.D., Grabowsky J., Schrader M., Liepke C., Jurgens M., Schulz-Knappe P., et al. Human beta-defensin-1: a urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res 1998, 3:315-323.
116. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000, 480:147-150.
117. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011, 117:4425-4433.
118. Kroot J.J.C., Tjalsma H., Fleming R.E., Swinkels D.W. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011, 57:1650-1669.
119. Yamaguchi H., Sasaki K., Satomi Y., Shimbara T., Kageyama H., Mondal M.S., et al. Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2. J Biol Chem 2007, 282:26354-26360.
120. An Z., Chen Y., Koomen J.M., Merkler D.J. A mass spectrometry-based method to screen for alpha-amidated peptides. Proteomics 2012, 12:173-182.
121. Lyons P.J., Fricker L.D. Substrate specificity of human carboxypeptidase A6. J Biol Chem 2010, 285:38234-38242.
122. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
123. Zolg J.W., Langen H. How industry is approaching the search for new diagnostic markers and biomarkers. Mol Cell Proteomics 2004, 3:345-354.
124. Good D.M., Zurbig P., Argiles A., Bauer H.W., Behrens G., Coon J.J., et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010, 9:2424-2437.
125. Jones A.G., Hattersley A.T. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 2013, 30:803-817.
126. Motiwala S.R., Januzzi J.L. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Clin Pharmacol Ther 2013, 93:57-67.
127. Mattsson N., Zegers I., Andreasson U., Bjerke M., Blankenstein M.A., Bowser R., et al. Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid beta42. Biomark Med 2012, 6:409-417.
128. Schrader M., Selle H. The process chain for peptidomic biomarker discovery. Dis Markers 2006, 22:27-37.
129. Frommberger M., Zurbig P., Jantos J., Krahn T., Mischak H., Pich A., et al. Peptidomic analysis of rat urine using capillary electrophoresis coupled to mass spectrometry. Proteomics Clin Appl 2007, 1:650-660.
130. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359:572-577.
131. Diamandis E.P. Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?. Clin Chem 2003, 49:1272-1275.
132. Carrette O., Demalte I., Scherl A., Yalkinoglu O., Corthals G., Burkhard P., et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 2003, 3:1486-1494.
133. Villanueva J., Philip J., Chaparro C.A., Li Y., Toledo-Crow R., DeNoyer L., et al. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 2005, 4:1060-1072.
134. Pailleux F., Beaudry F. Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry. Biomed Chromatogr 2012, 26:881-891.
135. Mesmin C., Dubois M., Becher F., Fenaille F., Ezan E. Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma. Rapid Commun Mass Spectrom 2010, 24:2875-2884.
136. van Winden A.W.J., van den Broek I., Gast M.W., Engwegen J.Y.M.N., Sparidans R.W., van Dulken E.J., et al. Serum degradome markers for the detection of breast cancer. J Proteome Res 2010, 9:3781-3788.
137. Stoeckli M., Chaurand P., Hallahan D.E., Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001, 7:493-496.
138. Balluff B., Schone C., Hofler H., Walch A. MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications. Histochem Cell Biol 2011, 136:227-244.
139. Minerva L., Boonen K., Menschaert G., Landuyt B., Baggerman G., Arckens L. Linking mass spectrometric imaging and traditional peptidomics: a validation in the obese mouse model. Anal Chem 2011, 83:7682-7691.
140. Slavoff S.A., Mitchell A.J., Schwaid A.G., Cabili M.N., Ma J., Levin J.Z., et al. Peptidomic discovery of short open reading frame-encoded peptides in human cells. Nat Chem Biol 2013, 9:59-64.
141. Kersten R.D., Yang Y., Xu Y., Cimermancic P., Nam S., Fenical W., et al. A mass spectrometry-guided genome mining approach for natural product peptidogenomics. Nat Chem Biol 2011, 7:794-802.